Clinical Trial Update: Offset of Ticagrelor's Effect on Endothelial Function as Assessed With Peripheral Arterial Tonometry (EndoPAT Assay)

View source ↗

Summary

A completed clinical trial evaluating how ticagrelor affects endothelial function, measured with EndoPAT, in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BRILINTA (ticagrelor)

Snippet

Sponsor: University of Patras | Conditions: Coronary Artery Disease, Endothelial Function | Status: COMPLETED